Search Results - "Cummings, Carrie"
-
1
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study
Published in Clinical cancer research (01-02-2020)“…A cryptic inv(16)(p13.3q24.3) encoding the fusion is associated with poor outcome in infants with acute megakaryocytic leukemia. We aimed to broaden our…”
Get full text
Journal Article -
2
Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets
Published in Molecular and cellular biology (01-02-2016)“…Acute myeloid leukemia (AML) is characterized by increased proliferation and blocked differentiation of hematopoietic progenitors mediated, in part, by altered…”
Get full text
Journal Article -
3
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
Published in Blood (15-02-2007)“…The impact of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) on subsequent allogeneic transplantation is uncertain. To better understand…”
Get full text
Journal Article -
4
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells
Published in Blood (08-10-2009)“…The preferentially expressed antigen in melanoma (PRAME) is expressed in several hematologic malignancies, but either is not expressed or is expressed at only…”
Get full text
Journal Article -
5
Discovery of U2AF1 neoantigens in myeloid neoplasms
Published in Journal for immunotherapy of cancer (12-12-2023)“…BackgroundMyelodysplastic syndromes (MDS) arise from somatic mutations acquired in hematopoietic stem and progenitor cells, causing cytopenias and predisposing…”
Get full text
Journal Article -
6
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
Published in Blood (15-06-2005)“…Germ-line heterozygous mutations in the hematopoietic transcription factor AML1 (RUNX1) have been identified in patients with familial platelet disorder with…”
Get full text
Journal Article -
7
Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation
Published in Experimental hematology (01-10-2005)“…An 11-year-old girl, presenting with fatigue and bruising, was found to be profoundly pancytopenic. Bone marrow exam and clinical evaluation were consistent…”
Get full text
Journal Article -
8
FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10
Published in Human heredity (01-01-2003)“…The gene for a novel nonsyndromic autosomal dominant thrombocytopenia has been previously mapped to a region on human chromosome 10p11-12 (THC2, OMIM number…”
Get more information
Journal Article -
9
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
Published in The Journal of clinical investigation (01-10-2020)“…Proteins created from recurrent fusion genes like CBFB-MYH11 are prevalent in acute myeloid leukemia (AML), often necessary for leukemogenesis, persistent…”
Get full text
Journal Article -
10
Custom High Throughput Drug Sensitivity Assay Reveals Therapeutic Options for Chronic Myeloid Leukemia Patients Resistant to or Intolerant of Tyrosine Kinase Inhibitors
Published in Blood (23-11-2021)“…Introduction. Tyrosine kinase inhibitors (TKIs) have revolutionized chronic phase (CP) chronic myeloid leukemia (CML) care with many patients achieving major…”
Get full text
Journal Article -
11
Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement
Published in Blood (23-11-2021)“…▪ Myeloid/lymphoid neoplasms associated with eosinophilia (MLN-Eo) and tyrosine kinase fusion genes include rearrangements of PDGFRB with over 30 different…”
Get full text
Journal Article -
12
A Shared SF3B1 Neoantigen Is Presented on Primary Malignant Cells and Induced Pluripotent Stem Cell-Derived Hematopoietic Lines
Published in Blood (05-11-2020)“…Myeloid malignancies are susceptible to immunologic destruction but antigen-specific T cell immunotherapies for these diseases are currently limited…”
Get full text
Journal Article -
13
Functional miRNA Expression Library Screen Identifies miRNAs That Alter Proliferation and Differentiation in Acute Myeloid Leukemia
Published in Blood (06-12-2014)“…Acute myeloid leukemia (AML) is characterized by increased self-renewal of leukemia stem/progenitor cells and failure of differentiation to mature myeloid…”
Get full text
Journal Article -
14
KDM7A Is Targeted By MiR-155 in Acute Myeloid Leukemia and Impacts Differentiation
Published in Blood (03-12-2015)“…Acute myeloid leukemia (AML) is a heterogeneous disease that develops secondary to the acquisition of mutations that disrupt cell differentiation,…”
Get full text
Journal Article -
15
Krüppel-like Factors KLF4 and KLF2 Regulate microRNA-150 Expression in Myeloid Leukemias
Published in Blood (06-12-2014)“…Background: Acute myeloid leukemia (AML) is characterized by increased self-renewal of leukemia stem/progenitor cells and failure of differentiation to mature…”
Get full text
Journal Article -
16
-
17
CD52 Expression In Leukemic Stem/Progenitor Cells
Published in Blood (19-11-2010)“…Abstract 2743 CD52 is a cell surface glycoprotein of unknown function that is expressed in B and T lymphocytes, macrophages, and monocytes, but is not…”
Get full text
Journal Article -
18
Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Normal and CML CD34+ Progenitor Cells Impairs Myeloid Differentiation
Published in Blood (16-11-2008)“…PRAME, or the Preferentially Expressed Antigen in Melanoma, is an attractive therapeutic target in cancer treatment. It has been described as a…”
Get full text
Journal Article -
19
-
20